Investor confidence in Turkey is shaken by the shock dismissal of the head of the central bank and the appointment of a new central banker with unorthodox ideas on how to tackle the country’s economic challenges, the increased production of the Covid-19 vaccine is creating shortages of other medicines, and Goldman Sachs bows to workplace complaints by junior bankers. 

Turkey’s lira tumbles after Erdogan sacks central bank chief

Push to make Covid vaccines causes US drug shortages

David Solomon commits to Saturdays off for Goldman Sachs bankers

See for privacy and opt-out information.

Transcripts are not currently available for all podcasts, view our accessibility guide.

Get alerts on FT News Briefing when a new story is published

Copyright The Financial Times Limited 2022. All rights reserved.
Reuse this content (opens in new window) CommentsJump to comments section

Comments have not been enabled for this article.

Follow the topics in this podcast